Enzymatica sign on as Official Cold and Flu Protection partner

New partnership to help reduce time lost to illness for athletes competing at the highest levels of the sport

We are pleased to announce Enzymatica, creators of ColdZyme, the market-leading cold and flu-like virus prevention product, will come on board as our Official Cold and Flu Protection partner for the 2025/26 season.

In a season where GB Snowsport athletes and staff will push themselves to the limits in the pursuit of success, the risk of cold and flu-like illnesses present a real challenge. Through this partnership, Enzymatica and GB Snowsport aim to help reduce time lost to illness, enabling the country’s best skiers and snowboarders to push themselves to the limit from the first to the last competitions of the season.

Claire Williams, GB Snowsport Head of Sport Sciences and Medicine, said:

“We’re delighted to have the support of ColdZyme coming into the new season. In a sport where the margins that dictate success can come down to a matter of millimetres, cold and flu-like viruses can have a real impact in training and competition.

“By working with ColdZyme, we will be working to ensure our athletes are supported in the best way possible ahead of one of the most significant seasons in recent British snowsport history.”

Charlotte Hodgkins Byrne, Director of Strategic Partnerships at Enzymatica, said:

“We are very pleased to be partnering with GB Snowsport throughout the 2025/26 season. Clinical studies have shown that ColdZyme can shorten the duration of virus-related respiratory infections, reduce symptoms, and decrease viral load.

“Supporting these athletes at such a pivotal – and exciting – stage is something we are extremely proud of, and we look forward to following their journey towards the Milano Cortina 2026 Winter Olympics and Paralympics.”

Enzymatica AB is a Swedish life science company specialising in enzyme-based medical devices that address respiratory health needs. The company’s flagship product, ColdZyme, is available in multiple markets. For more information, visit https://www.enzymatica.com.